CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share (CERO)

Historical Holders from Q4 2021 to Q1 2025

Type / Class
Equity / Common Stock, $0.0001 par value per share
Symbol
CERO on Nasdaq
Shares outstanding
5,169,697
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share (CERO) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ATWOOD BRIAN G 9.9% +46% $20,472 +$12,376 511,800 +153% Brian G. Atwood 31 Mar 2025
YK Bioventures Opportunities GP I, LLC 0% $680 17,002 YK Bioventures Opportunities GP I, LLC 13 Dec 2024

Institutional Holders of CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share (CERO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q1 0 $0 -$956,032 0
2024 Q4 13,323,470 $956,042 +$582,510 $0.0600 19
2024 Q3 3,425,662 $318,485 +$159,248 $0.0933 16
2024 Q2 1,867,063 $557,115 +$77,507 $0.2990 14
2024 Q1 1,515,173 $4,651,346 -$2,752,940 $3.07 8
2023 Q4 54,600 $600,600 -$206,404 $11.00 1
2023 Q3 830,140 $7,332,447 -$3,254,594 $10.86 10
2023 Q2 976,580 $10,615,899 -$2,059,999 $10.90 13
2023 Q1 1,230,115 $11,484,438 -$85,887,627 $10.68 14
2022 Q4 9,845,770 $101,108,715 -$49,456,024 $10.27 45
2022 Q3 15,151,664 $152,959,000 +$5,501,422 $10.09 65
2022 Q2 14,419,635 $144,538,000 +$6,286,552 $10.02 54
2022 Q1 13,715,709 $137,190,000 +$31,684,673 $10.00 45
2021 Q4 10,510,900 $104,167,000 +$90,376,011 $9.91 36